CAM
Cormorant Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Sell |
1,100,000
-500,000
| -31% | -$8.73M | 1.43% | 18 |
|
|
2025
Q1 | $20.1M | Buy |
1,600,000
+1,100,000
| +220% | +$13.8M | 1.51% | 20 |
|
|
2024
Q4 | $5.28M | Buy |
+500,000
| New | +$5.28M | 0.29% | 37 |
|
|
2021
Q3 | – | Sell |
-239,099
| Closed | -$7.39M | – | 99 |
|
|
2021
Q2 | $7.39M | Sell |
239,099
-260,901
| -52% | -$8.06M | 0.25% | 68 |
|
|
2021
Q1 | $21.8M | Hold |
500,000
| – | – | 0.49% | 42 |
|
|
2020
Q4 | $23.2M | Buy |
+500,000
| New | +$23.2M | 0.55% | 39 |
|